Compare CVS Health Corp (CVS) vs Five Below Inc (FIVE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Five Below Inc — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while Five Below Inc trades at $214.73 (market cap $11.55B). The key difference: CVS Health Corp is far larger — about 9.7× Five Below Inc's market cap, and CVS Health Corp pays a 3.03% dividend while Five Below Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Five Below Inc for 46 Days on average.
| CVS | FIVE | |
|---|---|---|
Market Cap | $112.29B | $11.55B |
Volume | 7,763,676 | 1,120,554 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $262.72 |
52-Week Low | $70.08 | $138.49 |
Typical Hold Time | 83 Days | 46 Days |
Enterprise Value | $174.64B | $12.40B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, down 0.17% with a bearish technical signal. The company shows strong revenue growth to $402.1B in 2025 and has beaten earnings estimates for three consecutive quarters. Analyst consensus is overwhelmingly bullish with 85% buy ratings and a $111.20 price target representing 27% upside. Recent news highlights Aetna's 2027 Medicare plan enhancements and quarterly dividend declarations.
CVS presents a compelling value opportunity with attractive valuation metrics (P/E 23.17, P/S 0.27) and strong analyst support. Key risks include reimbursement pressure, regulatory scrutiny from ongoing investigations, and declining net margins. The stock's current technical weakness contrasts with solid fundamentals and positive earnings momentum.
Five Below (FIVE) trades at $209.56, up 2.61% today, showing strong momentum with three consecutive quarterly earnings beats. The stock faces technical headwinds with bearish moving averages but maintains solid fundamentals including 40.3% gross margins and 28.3% ROE. Recent news highlights strategic growth initiatives including a $600 million buyback and board appointments, while analysts project significant upside to the $298.44 consensus target.
FIVE presents a compelling growth story with 60% analyst buy ratings and projected revenue growth to $5.3B in 2026. However, premium valuation multiples and execution risks amid consumer spending pressures require careful monitoring. The stock's technical weakness contrasts with strong fundamental prospects, creating potential opportunity for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →
